(Q38092003)

28 August 2017

Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis (English)

1 reference

28 August 2017

0 references

1 reference

hepatocellular carcinoma

1 reference

1 reference

3

1 reference

28 August 2017

Caroline D M Witjes

1

1 reference

28 August 2017

Susanna M van Aalten

2

1 reference

28 August 2017

Gerard J J M Borsboom

4

1 reference

28 August 2017

Robert A de Man

5

1 reference

28 August 2017

Cornelis Verhoef

6

1 reference

28 August 2017

Jan N M Ijzermans

7

1 reference

28 August 2017

language of work or name

1 reference

12 May 2012

1 reference

28 August 2017

Hepatology international

1 reference

28 August 2017

7

1 reference

28 August 2017

1

1 reference

28 August 2017

59-64

1 reference

https://scigraph.springernature.com/pub.10.1007/s12072-012-9374-3

28 August 2017

0 references

cites work

Identification of osteopontin as a novel marker for early hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601272

Management of hepatocellular carcinoma: An update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601272

Diagnosis of hepatocellular carcinoma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601272

Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601272

Management of hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601272

Are increasing 5-year survival rates evidence of success against cancer?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601272

Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601272

Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601272

SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC

31 August 2018

1 reference

12 December 2020

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma

1 reference

12 December 2020

Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients

1 reference

12 December 2020

GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma

1 reference

12 December 2020

Estimating Diagnostic Accuracy from Multiple Conflicting Reports

1 reference

12 December 2020

10.1007/S12072-012-9374-3

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference

28 August 2017

PubMed publication ID

23519638

1 reference